Call Us: +44 (0) 1752 753723[email protected]

AstraZeneca, Harvard Stem Cell Institute enter five-year diabetes research collaboration

AstraZeneca has signed a five-year collaboration deal with the Harvard Stem Cell Institute (HSCI), under which the parties will investigate adapting a technique to create human beta cells from stem cells for use in finding new treatments for diabetes. As part of the deal, AstraZeneca will provide funding for...